市場調查報告書
商品編碼
1615220
益生菌菌株的全球市場:成長,未來展望,競爭分析 (2024年~2032年)Probiotic Strains Market - Growth, Future Prospects and Competitive Analysis, 2024 - 2032 |
益生菌菌株市場圍繞著特定益生菌菌株的商業化和應用。當以適當的量施用時,這些微生物會為宿主帶來健康益處。從歷史上看,益生菌主要與優格和其他發酵食品有關。然而,隨著科學認識的增加,針對特定健康問題的特定菌株的分離已成為一個蓬勃發展的市場。由於健康意識的提高和應用的擴大,益生菌菌株市場預計從 2024 年到 2032 年將以 7.8% 的複合年增長率成長。
市場驅動力:腸道健康意識不斷增強
推動益生菌菌株市場的主要因素之一是人們越來越意識到腸道健康在整體健康中的重要作用。有句話說: "一切疾病都始於腸道" 。現代科學越來越支持這一點,腸道健康不僅與消化系統疾病有關,還與更廣泛的健康問題有關,從心理健康到免疫系統功能。例如,《精神藥理學》雜誌發表的研究表明,乳酸菌和雙歧桿菌等益生菌菌株可以產生和輸送γ-氨基丁酸(GABA)等神經活性物質,對情緒有直接影響。
市場機會:營養補充品和化妝品領域的擴張
益生菌菌株在營養保健品和化妝品領域正在迅速成長。人們不斷尋求天然的健康解決方案,因此益生菌菌株越來越多地被納入營養補充劑中。此外,美容護膚產業不再只關注美觀,而是強調整體皮膚健康。 《國際女性皮膚病學雜誌》上發表的一篇論文強調,益生菌可能成為皮膚護理領域的潛在遊戲規則改變者,解決從痤瘡到衰老等一系列問題,並為市場成長提供主要途徑。
市場約束:嚴格的監理架構
然而,益生菌株市場並非一帆風順。一個關鍵的抑制因素是圍繞健康聲明的嚴格監管環境。在許多地區,產品需要經過嚴格的測試和驗證過程才能貼上含有益生菌的標籤並聲稱具有相關的健康益處。例如,歐洲食品安全局(EFSA)對益生菌相關的健康聲明特別嚴格,由於缺乏證據而拒絕了其中許多聲明。
市場挑戰:菌株穩定性與生存能力
除了監管方面的挑戰外,益生菌菌株的穩定性和活力還面臨具體的挑戰。確保這些菌株存活並持續有效直至到達消費者手中絕非易事。溫度、pH 值和氧氣水平等因素會極大地影響益生菌菌株的活力。正如《世界胃腸病學雜誌》所引用的那樣,許多產品經過測試,發現其所含的活細菌遠低於規定的水平,或者根本沒有,這凸顯了向最終消費者提供強大而有效的產品的關鍵挑戰。
按類型細分
益生菌菌株市場主要按類型細分,包括乳酸桿菌、鼠李糖乳桿菌 GG 和雙歧桿菌等主要菌株。 2023年,嗜酸乳桿菌在收入方面佔據市場主導地位,這主要是由於其在治療從乳糖不耐症到某些皮膚病等疾病的應用。然而,鼠李糖乳桿菌 GG 片段顯示出最高的平均年增長率 (CAGR)。該菌株已廣受歡迎,因為經過充分研究,它可以有效治療和預防許多疾病,特別是胃腸道感染和抗生素相關性腹瀉。
依形狀細分
從形態來分析市場,益生菌市場分為乾型和液體型。從歷史上看,乾燥領域在 2023 年佔據了很大的銷售額。乾燥益生菌主要為膠囊或粉末形式,與液體相比,保質期更長,更容易儲存,並且需要更少的運輸。然而,預計 2024 年至 2032 年液體類型的複合年增長率將顯著。這種成長是由康普茶、克菲爾和益生菌注射液等飲用益生菌的需求不斷增長所推動的。
區域洞察
從地區來看,北美地區成為 2023 年最大的收入貢獻者。高度認可、研發方面的大量投資以及成熟的營養保健品和食品和飲料行業等因素支持了該地區市場的成功。然而,預計 2024 年至 2032 年亞太地區的複合年增長率最高。這一趨勢是由中國和印度等國家的爆炸性增長推動的,這些國家的特徵是人口快速城市化,可支配收入不斷增加,對健康和保健產品的偏好日益增強。
競爭趨勢
在競爭格局中,Hansen Holding A/S、Probi、Aumgene Bioscience、Virchow Biotech Private Limited、Merck KGaA、I. du Pont de Nemours and Company、Koninklijke DSM NV、Ganeden、Lesaffre、Essum AB、Vario Dairy、 BioGaia 、森永乳業有限公司、Snowboard Dairy Co., Ltd.、達能、Kerry Plc、Culturelle、Urex生物技術等公司是領跑者。 2023年,這些公司採取了從併購到大規模研發投資的策略來確保市場主導地位。例如,杜邦公司收購健康增強產品顯示其打算加強在益生菌領域的地位。市場參與者也在深入研究,以發現具有獨特健康益處的新菌株,確保穩定推出滿足不斷變化的消費者需求的產品。
本報告回答的主要問題
影響益生菌菌株市場成長的關鍵微觀和宏觀環境因素有哪些?
在目前和預測期間內,產品領域和地區的主要投資領域是什麼?
估計/預測/市場預測(直到 2032 年)
哪個細分市場在預測期間內複合年增長率最快?
哪個細分市場擁有較大的市場佔有率,為什麼?
低收入和中等收入國家是否正在投資益生菌菌株市場?
益生菌菌株市場中最大的區域市場是哪一個?
亞太、拉丁美洲、中東/非洲等新興市場的市場趨勢與趨勢如何?
推動益生菌菌株市場成長的主要趨勢是什麼?
主要競爭對手是什麼以及他們提高在全球益生菌菌株市場的影響力的關鍵策略是什麼?
The probiotic strains market revolves around the commercialization and application of specific strains of probiotics. These microorganisms, when administered in adequate amounts, confer health benefits to the host. Historically, probiotics were primarily associated with yogurt and other fermented foods. However, as scientific understanding deepened, the isolation of specific strains to target particular health concerns has become a burgeoning market. Probiotic Strains Market is estimated to grow at a CAGR of 7.8% from 2024 to 2032, driven by rising health consciousness and expanding applications.
Market Driver - Rising Awareness of Gut Health
One of the primary drivers propelling the Probiotic Strains Market is the mounting awareness of the critical role of gut health in overall well-being. There's an adage, 'All diseases begin in the gut.' Modern science increasingly supports this, associating gut health with not only digestive disorders but also with broader health issues, from mental health to immune system functionality. For instance, Psychopharmacology published a study showing that probiotic strains like Lactobacillus and Bifidobacterium can produce and deliver neuroactive substances such as gamma-aminobutyric acid (GABA), which have direct effects on mood.
Market Opportunity - Expansion in Nutraceutical and Cosmetic Sectors
There's a burgeoning opportunity for probiotic strains in the nutraceutical and cosmetic sectors. People are continually seeking natural solutions to health concerns, and as a result, the incorporation of probiotic strains into dietary supplements is on the rise. Furthermore, the beauty and skincare industry is no longer just about aesthetics; it's increasingly about overall skin health. A publication in the International Journal of Women's Dermatology highlighted that probiotics could be potential game-changers in skincare, combating issues from acne to aging, and presenting a massive avenue for market growth.
Market Restraint - Stringent Regulatory Frameworks
However, not everything is smooth sailing for the Probiotic Strains Market. A significant restraint is the stringent regulatory landscape surrounding health claims. In many regions, for a product to be labeled as containing probiotics and to tout associated health benefits, there are rigorous testing and validation processes. The European Food Safety Authority (EFSA), for example, has been particularly strict about health claims related to probiotics, rejecting many due to insufficient evidence.
Market Challenge - Stability and Viability of Strains
Beyond regulatory challenges, there's a tangible challenge related to the stability and viability of probiotic strains. Ensuring that these strains remain alive and effective when reaching the consumer is no small feat. Factors such as temperature, pH, and oxygen levels can dramatically impact the viability of probiotic strains. As cited by The World Journal of Gastroenterology, many products, when tested, contain far fewer live organisms than stated, or sometimes none at all, highlighting the critical challenge of delivering a potent and efficacious product to the end consumer.
Segmentation by Type
The probiotic strains market is prominently segmented by type, with key strains including Lactobacillus acidophilus, Lactobacillus rhamnoses GG, Bifidobacterium bifidum, among others. In 2023, Lactobacillus acidophilus dominated the market in terms of revenue, primarily due to its broad-spectrum application in treating conditions ranging from lactose intolerance to certain skin disorders. However, the Lactobacillus rhamnoses GG segment exhibited the highest Compound Annual Growth Rate (CAGR). This strain has gained traction because of its well-researched benefits and efficacy in treating and preventing a plethora of conditions, notably gastrointestinal infections and antibiotic-associated diarrhea.
Segmentation by Form
On analyzing the market by form, the probiotics market bifurcates into dry and liquid forms. Historically, the dry segment held the lion's share of the revenue in 2023. Dry probiotics, primarily in capsule or powdered forms, offer longer shelf-life, easy storage, and hassle-free transportation compared to their liquid counterparts. However, the liquid form segment is anticipated to witness a remarkable CAGR from 2024 to 2032. This growth can be attributed to the increasing demand for drinkable probiotics like kombucha, kefir, and probiotic shots, driven by consumers' inclination toward ready-to-drink health beverages.
Regional Insights
Geographically, the North American region emerged as the largest revenue contributor in 2023. Factors such as high awareness levels, significant investments in R&D, and the presence of well-established nutraceutical and food & beverage industries underpin the market's success in this region. Nevertheless, the Asia-Pacific region is expected to register the highest CAGR from 2024 to 2032. The explosive growth in countries like China and India, characterized by rapidly urbanizing populations with increasing disposable incomes and a growing penchant for health and wellness products, is driving this trend.
Competitive Trends
In the competitive landscape, companies like Hansen Holding A/S, Probi, Aumgene Bioscience, Virchow Biotech Private Limited, Merck KGaA, I. du Pont de Nemours and Company, Koninklijke DSM N.V., Ganeden, Lesaffre, Essum AB, Valio Dairy, BioGaia, Morinaga Milk Industry Co., Ltd., Snow Board Milk Products Co., Ltd., Danone, Kerry Plc, Culturelle, Urex Biotech are some of the front runners. In 2023, these players adopted strategies ranging from mergers and acquisitions to extensive R&D investments to ensure market dominance. For instance, DuPont's acquisition of Health Enhancement Products signified its intent to bolster its position in the probiotics space. Market players are also delving deep into research to uncover novel strains with unique health benefits, ensuring a steady stream of product launches that cater to evolving consumer demands.
Historical & Forecast Period
This study report represents an analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.
The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of Probiotic Strains market are as follows:
Research and development budgets of manufacturers and government spending
Revenues of key companies in the market segment
Number of end users & consumption volume, price, and value.
Geographical revenues generated by countries considered in the report
Micro and macro environment factors that are currently influencing the Probiotic Strains market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.
Market Segmentation
Type
Form
End-Use
Region Segment (2022-2032; US$ Million)
North America
U.S.
Canada
Rest of North America
UK and European Union
UK
Germany
Spain
Italy
France
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East and Africa
GCC
Africa
Rest of Middle East and Africa
Key questions answered in this report
What are the key micro and macro environmental factors that are impacting the growth of Probiotic Strains market?
What are the key investment pockets concerning product segments and geographies currently and during the forecast period?
Estimated forecast and market projections up to 2032.
Which segment accounts for the fastest CAGR during the forecast period?
Which market segment holds a larger market share and why?
Are low and middle-income economies investing in the Probiotic Strains market?
Which is the largest regional market for Probiotic Strains market?
What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
Which are the key trends driving Probiotic Strains market growth?
Who are the key competitors and what are their key strategies to enhance their market presence in the Probiotic Strains market worldwide?
FIG. 10Market Positioning of Key Probiotic Strains Market Players, 2023
FIG. 11Global Probiotic Strains Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2032